Cleared Traditional

K244007 - ArteVu

K244007 is an FDA 510(k) clearance for ArteVu, manufactured by Cardio Ring Technologies, Inc. Taiwan Branch. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 216-day FDA review.

K244007 · Cardio Ring Technologies, Inc. Taiwan Branch · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2025
Decision
216d
Days
Class 2
Risk

K244007 is an FDA 510(k) clearance for the ArteVu. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Cardio Ring Technologies, Inc. Taiwan Branch (New Taipei City, TW). The FDA issued a Cleared decision on July 30, 2025 after a review of 216 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Cardio Ring Technologies, Inc. Taiwan Branch devices

FDA 510(k) Submission Details - K244007

510(k) Number K244007 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 26, 2024
Decision Date July 30, 2025
Days to Decision 216 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
91d slower than avg
Panel avg: 125d · This submission: 216d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

RQM+
Alexia Haralambous

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 565
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K244007.
Automatic Upper Arm Blood Pressure Monitor (BA-831X, BA-832X, BA-833X, BA-837X, BA-838X, BA-842X, BA-843X, BA-845X, BA-847X, BA-849X, BA-851X, BA-852X, BA-855X, BA-835, BA-836, BA-839, BA-840, BA-856)
K250231 · Dongguan E-Test Technology Co., Ltd. · Sep 2025
Microlife Upper Arm Automatic Digital Blood Pressure Monitor, Model BP Progress (BP3T01-1B)
K251120 · Microlife Corporation · Aug 2025
iHealth Compare Wireless Blood Pressure Monitor(BP-300C)
K251113 · Andon Health Co, Ltd. · Aug 2025
Automatic Blood Pressure Monitor (CH-S691L, CH-B607, CH-B606, CH-S692L, CH-S602, CH-W701L, CH-S693L, CH-B601L, CP-B01, CH-S603)
K251102 · Cemho Medical Technology (Guangdong) Co., Ltd. · Jul 2025
Electronic Sphygmomanometers (ZH-X9, ZH-X12, ZH-X16, ZH-X17, ZH-X18, ZH-X19, ZH-X23, ZH-X24)
K250185 · Jiangxi Aicare Medical Technology Co., Ltd. · Jul 2025
G0 Blood Pressure Monitoring System (G0)
K250415 · Aktiia SA · Jul 2025